ロード中...

Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal Transplantation

BACKGROUND: Acute rejection remains a major problem in renal transplantation and represents one of the most important causes of chronic allograft dysfunction and late graft loss. Daclizumab is a genetically engineered human IgG1 monoclonal antibody that binds specifically to the α chain of the inter...

詳細記述

保存先:
書誌詳細
主要な著者: Saghafi, Hossein, Rahbar, Khosrow, Nobakht Haghighi, Ali, Qoreishi, Mohammad, Safdari, Farshad
フォーマット: Artigo
言語:Inglês
出版事項: Kowsar 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3614279/
https://ncbi.nlm.nih.gov/pubmed/23573470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/numonthly.1806
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!